2022 Annual Meeting | Frontiers in Neuroscience Plenary Session

Date Wednesday 04/06/22

Time 09:15 AM - 11:30 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Plenary Session

Director(s) Paul M. George, MD, PhD, MSE, FAAN

Topic(s) General Neurology, Multiple Sclerosis, Aging, Dementia, and Behavioral Neurology, Infectious Disease, Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives This plenary session features basic and translational research related to clinical issues of importance. Hear from six outstanding speakers as they summarize their recent research finding and dive into the clinical implications of the results.

CME Available 2.25 CME credits

Program Materials Program Evaluations

Event Timeline
09:15 AM - 09:35 AM PDT	Speaker	Roles of Astrocytes in CNS Inflammation Francisco J. Quintana, PhD
09:35 AM - 09:55 AM PDT	Speaker	Tau Protein as a Therapeutic Target and Biomarker for Neurological Disease Adam L. Boxer, MD, PhD
09:55 AM - 10:15 AM PDT	Speaker	Neurobiology of COVID-19 Robyn S. Klein, MD, PhD
10:15 AM - 10:35 AM PDT	Speaker	Mapping the Connectivity of Consciousness Brian Edlow, MD
10:35 AM - 10:55 AM PDT	Speaker	Mapping the ALS Exposome: A Step Towards Prevention Eva Feldman, MD, PhD, FAAN
10:55 AM - 11:15 AM PDT	Speaker	mRNA Vaccines for Therapeutic Applications in Neuroscience Michael Lim, MD

Faculty Disclosures
Brian Edlow, MD	Dr. Edlow has received research support from NIH.
Eva Feldman, MD, PhD, FAAN	The institution of Dr. Feldman has received research support from National Institutes of Health. The institution of Dr. Feldman has received research support from Centers for Disease Control and Prevention / Agency for Toxic Substances and Disease Registry. The institution of Dr. Feldman has received research support from Juvenile Diabetes Research Foundation. Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Editorial Board Member with Journal of the Peripheral Nervous System, Experimental Neurology, Nature Neurology Reviews, Neurobiology of Disease, NeuroRx, Journal of Neurology Neurosurgery and Psychiatry, Scientific Reports, Lancet Neurology, Med (Cell Press Journal) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Editor-in-Chief with Oxford University Press Contemporary Neurology Series that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, and Chair of Section 07 with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Associate Editor with Annals of Neurology that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Governance Committee Chair with American Neurological Association that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, Chair of Section 07, Neuroscience Forum, Council Member with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Committee on Making ALS a Livable Disease Member with National Academy of Sciences, Engineering, and Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Member, Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) External Oversight Committee with National Institutes of Health that is relevant to AAN interests or activities.
Adam L. Boxer, MD, PhD	An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Rock. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Humana. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AZTherapeutics. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arkuda. Dr. Boxer has stock in Arvinas. An immediate family member of Dr. Boxer has stock in AZtherapies. Dr. Boxer has stock in TrueBinding. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project. Dr. Boxer has received research support from Rainwater Charitable Foundation. The institution of Dr. Boxer has received research support from Association for Frontotemporal Degeneration.
Francisco J. Quintana, PhD	Dr. Quintana has nothing to disclose.
Michael Lim, MD	Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for arbor. Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tocagen. Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tocagen. Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyramid bio. Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InSightec. Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanianoia. Michael Lim, MD has received personal compensation in the range of $0-$499 for serving as a Consultant for Biohaven. Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hemispherian. Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for black diamond therapeutics. Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Michael Lim, MD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker. Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Pennsylvania. Michael Lim, MD has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Egret Therapeutics. Michael Lim, MD has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Covington. Michael Lim, MD has received stock or an ownership interest from Egret Therapeutics. Michael Lim, MD has received intellectual property interests from a discovery or technology relating to health care. Michael Lim, MD has received publishing royalties from a publication relating to health care. Michael Lim, MD has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Robyn S. Klein, MD, PhD	No disclosure on file
Paul M. George, MD, PhD, MSE, FAAN	Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH.